RxDoctor Payments Data

Hiten Patel, MD

Family Medicine · Charlotte, NCNPI 1861485542

Payments from drug & device makers

$349in general payments, 2019–2025

Across 19 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$126
  • Novo Nordisk$64
  • Exact Sciences$36
  • Boehringer Ingelheim$35
  • Inari Medical, Inc.$23
  • Biohaven Pharmaceuticals, Inc.$22
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$33496%
  • Education$154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$349 in reported general payments places this provider in the 50th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$61,775
Medicare patients
133
Services billed
854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide55$96,612
JardianceEmpagliflozin48$47,257
MounjaroTirzepatide28$45,580
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$43,866
OzempicSemaglutide20$33,843
XareltoRivaroxaban14$16,296
JanuviaSitagliptin Phosphate15$10,905
EliquisApixaban15$8,925
Atorvastatin Calcium446$3,116
Rosuvastatin Calcium252$2,692
Wixela InhubFluticasone Propion/Salmeterol11$2,607
Amlodipine Besylate447$2,052
Levothyroxine Sodium164$1,626
Lisinopril265$1,623
Testosterone12$1,593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$35$47,25748 claims
GSKTrelegy Ellipta$14$43,86635 claims
Novo NordiskOzempic$64$33,84320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →